Amneal Starts Seeking International Partners

Part Of A Turnaround Plan Under Patels

In a bid to make better use of Amneal’s US portfolio and pipeline, the company is looking for international licensing partners, especially in Eastern Europe and China, as its new management team looks to restore growth and revive profit margins.

Partnership
Amneal is looking for international licensing partners, particularly in Eastern Europe and China • Source: Shutterstock

Making better commercial use of its US marketed portfolio and pipeline by licensing assets to international partners forms part of a major turnaround plan for Amneal Pharmaceuticals unveiled by co-CEOs Chirag and Chintu Patel three months after they resumed control following the departure in early August of former CEO Rob Stewart and executive chairman Paul Bisaro.

Other elements of the plan laid out by the Patel brothers, who founded Amneal in 2002 and grew it into...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business